SKI Market

A+| A| A-|

Indian Indices

Sensex

77,664.00 -852.49
( -1.09%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

38.31

756.53

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

Skyline Millars reports standalone net loss of Rs 0.23 crore in the September 2025 quarter

Nov 13,2025

Net Loss of Skyline Millars reported to Rs 0.23 crore in the quarter ended September 2025 as against net loss of Rs 0.17 crore during the previous quarter ended September 2024. Sales reported to Rs 0.70 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.70	0	0
OPM %	-42.86	0	-
PBDT	-0.23	-0.16	-44
PBT	-0.23	-0.16	-44
NP	-0.23	-0.17	-35

77,664.00 -852.49 ( -1.09%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)